M&A: PHIBRO ANIMAL HEALTH CORP

Form Type: 8-K/A

Filing Date: 2025-01-07

Corporate Action: Acquisition

Type: Update

Accession Number: 000155837025000053

Comments: On October 31, 2024, Phibro Animal Health Corporation filed a Current Report on Form 8-K regarding the completion of its acquisition of the medicated feed additive product portfolio and related assets from Zoetis Inc. This report serves to amend the previous Form 8-K to update financial details pertaining to the acquisition. The Company filed detailed financial statements for the assets acquired and liabilities assumed as well as pro forma financial information to illustrate potential impact on the Company's results following the acquisition. The financial exhibits include audited and unaudited statements as of various dates, demonstrating the financial standing before and after the transaction. The unaudited pro forma financial information evaluates the combined results of Phibro and the acquired MFA Product Portfolio for the fiscal year ending June 30, 2024. The amendment does not change the core information in the original Form 8-K but provides additional clarity on the financial implications of the acquisition.

Document Link: View Document

Additional details:

Financial Statements Of Business Acquired: The audited Special Purpose Statements of Assets Acquired and Liabilities Assumed of the MFA Product Portfolio of Zoetis as of December 31, 2023 and December 31, 2022, and related revenue and expense statements are filed as Exhibit 99.1.

Pro Forma Financial Information: Unaudited pro forma condensed combined financial information filed as Exhibit 99.3 for the Company and the MFA Product Portfolio of Zoetis for the year ended June 30, 2024.

Financial Statements Exhibits Descriptions: Exhibits include consent of KPMG LLP, special purpose statements for the MFA Product Portfolio from various periods, and the pro forma financial information.